Related Experiment Video
Updated: Jan 28, 2026

Adult and Embryonic Skeletal Muscle Microexplant Culture and Isolation of Skeletal Muscle Stem Cells
Published on: September 21, 2010
Prospective application of stem cells to prevent post-operative skeletal fibrosis
Xiaolei Li1,2, Song Chen3, Lianqi Yan1
1Department of Orthopaedics, Orthopaedics Institute, Clinical Medical College of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou, Jiangsu, 225001, China.
Abstract:
Post-operative skeletal fibrosis is considered one of the major complications causing dysfunction of the skeletal system and compromising the outcomes of clinical treatment. Limited success has been achieved using current therapies; more effective therapies to reduce post-operative skeletal fibrosis are needed. Stem cells possess the ability to repair and regenerate damaged tissue. Numerous studies show that stem cells serve as a promising therapeutic approach for fibrotic diseases in tissues other than the skeletal system by inhibiting the inflammatory response and secreting favorable cytokines through activating specific signaling pathways, acting as so-called medicinal signaling cells. In this review, current therapies are summarized for post-operative skeletal fibrosis. Given that stem cells are used as a promising therapeutic approach for fibrotic diseases, little effort has been undertaken to use stem cells to prevent post-operative skeletal fibrosis. This review aims at providing useful information for the potential application of stem cells in preventing post-operative skeletal fibrosis in the near future. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1236-1245, 2019.
Insights
Post-operative skeletal fibrosis hinders skeletal function and treatment outcomes. This review explores stem cell therapy as a promising strategy to prevent this condition, leveraging their regenerative and anti-inflammatory properties.
Area of Science:
- Orthopaedic Research
- Regenerative Medicine
- Fibrosis Research
Background:
- Post-operative skeletal fibrosis is a significant complication impacting skeletal function and clinical treatment success.
- Current therapeutic options for skeletal fibrosis have limited efficacy, highlighting the need for novel approaches.
- Stem cells are recognized for their tissue repair capabilities and therapeutic potential in non-skeletal fibrotic diseases.
Purpose of the Study:
- To review current therapies for post-operative skeletal fibrosis.
- To explore the potential of stem cells in preventing post-operative skeletal fibrosis.
- To provide insights for future applications of stem cells in this area.
Main Methods:
- Literature review of current therapies for post-operative skeletal fibrosis.
- Analysis of stem cell mechanisms (e.g., anti-inflammatory, cytokine secretion) in fibrotic disease models.
- Synthesis of existing research on stem cell applications in non-skeletal fibrotic conditions.
Main Results:
- Current therapies for skeletal fibrosis show limited success.
- Stem cells act as medicinal signaling cells, modulating inflammation and promoting tissue repair.
- Evidence suggests stem cells are effective in treating fibrotic diseases in various tissues.
Conclusions:
- There is a significant need for more effective treatments for post-operative skeletal fibrosis.
- Stem cells show promise as a therapeutic strategy for preventing skeletal fibrosis.
- Further research into stem cell applications could lead to novel preventative treatments for skeletal fibrosis.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Adult Stem Cells
Embryonic Stem Cells
Cancer Prevention
Some...
Induced Pluripotent Stem Cells

